A groundbreaking clinical trial funded by the National Institutes of Health (NIH) has revealed a promising strategy to combat high blood pressure, a major risk factor for cardiovascular disease and death. The study, conducted at 36 federally qualified health centers (FQHCs) in Louisiana and Mississippi, demonstrates the effectiveness of a team-based intervention approach in significantly reducing systolic blood pressure among low-income participants.
The intervention strategy, which included intensive blood-pressure management, tracking and feedback to providers, health coaching on lifestyle changes and medication adherence, and home blood-pressure monitoring, proved to be a game-changer. Compared to enhanced usual care, the team-based approach led to a remarkable 15 mm Hg reduction in systolic blood pressure, compared to just 9 mm Hg in the control group. This difference could potentially result in a 10% reduction in cardiovascular events, according to prior research.
The study's findings are particularly significant given the high prevalence of hypertension and low control rates among low-income Americans. Uncontrolled high blood pressure affects 37 million U.S. adults, and the study's participants had long-standing, treated but uncontrolled hypertension. The team-based model not only reduced provider burden but also empowered patients through self-management and treatment adherence.
The cost-effectiveness of the intervention is another crucial aspect. The team-based intervention averaged around $760 per patient, which is significantly less expensive than treating resultant heart conditions. This affordability makes it a viable solution for a population that often faces financial barriers to healthcare.
NIH Director Jay Bhattacharya, M.D., Ph.D., emphasized the importance of evidence-based strategies to address the lack of treatment for uncontrolled hypertension among low-income Americans. He stated, 'This study shows us that we can deploy an affordable, tested program to help reduce the burden of heart disease in this population.'
The study's success has broader implications for primary care settings and underserved populations. Researchers believe that these strategies can be scaled to other healthcare environments, potentially improving hypertension control and reducing the disease burden. The National Heart, Lung, and Blood Institute (NHLBI), part of the NIH, plans to further explore and support such initiatives.
This clinical trial, led by researchers at the University of Texas Southwestern Medical Center and Tulane University, highlights the potential of team-based care in addressing a critical public health issue. The findings encourage the adoption of similar interventions in healthcare systems to improve patient outcomes and reduce the long-term costs associated with uncontrolled hypertension.
